2022 annual financial data
Inovio Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was -2,607.35%.
Operating income was -267,573,520 USD and net income was -279,818,065 USD.
Operating cash flow was -216,215,421 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,262,268 USD
- Operating income
- -267,573,520 USD
- Net income
- -279,818,065 USD
- Operating cash flow
- -216,215,421 USD